Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Management of Onychomycosis in the Face of Emerging Terbinafine Resistance

Description

This transcript consists of the introductory remarks at a session on the management of onychomycosis amidst the rising issue of terbinafine resistance. The speaker begins by addressing the audience, ensuring everyone is seated and ready to start on time. Housekeeping announcements highlight the locations of exits, remind attendees to silence their phones, and provide emergency protocol guidelines, including a contact number for emergencies and instructions in case of fire. The importance of conflict of interest disclosures is emphasized, along with the inclusion of a Q&A session for audience interaction. The speaker introduces the first presenter, Dr. Gupta, who will discuss the key topic of managing onychomycosis in light of the challenges posed by terbinafine resistance. The session aims to maintain a strict schedule with time management measures in place for speakers.

Conclusions

  • Emerging terbinafine resistance poses a significant challenge in the management of onychomycosis.
  • Alternative treatment options must be explored due to the limitations of terbinafine effectiveness.
  • Ongoing research is crucial to understand the mechanisms of terbinafine resistance in fungal species.
  • Clinicians need to stay updated on the latest management strategies for onychomycosis in light of resistance patterns.
  • A multidisciplinary approach may enhance the management of patients affected by onychomycosis.